Clinical Trial

CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial

Study acronym: CAVALIER
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The CAlcium and VAsopressin following Injury Early Resuscitation (CAVALIER) Trial is a proposed 4 year, double-blind, mutli-center, prehospital and early in hospital phase randomized trial designed to determine the efficacy and safety of prehospital calcium and early in hospital vasopressin in patients at risk of hemorrhagic shock.
Protocol Amendment History 22 amendments
This ClinicalTrials.gov record has been amended 22 times since 2023-07-14; most recent amendment 2026-06-01.
Status change: Not Yet Recruiting → Recruiting 2024-06-20
Trial Details
NCT Number NCT05958342
Lead Sponsor Jason Sperry
Collaborators: United States Department of Defense
Conditions Trauma, Hemorrhage
Enrollment 1,050 participants
Start Date 2024-06-30
Primary Completion 2027-03 (estimated)
Study Completion 2028-03 (estimated)
Updated on ClinicalTrials.gov 2026-08-06